Thanks for emailing that article!
Save the date: February 10, 2022
February 10, 2022
6:00 pm - 9:00 pm
It's time to celebrate! Mark your calendars for Glaucoma Research Foundation’s Annual Gala on February 10, 2022 at the Grand Hyatt Union Square in San Francisco.
Next year marks the 20th year of the first Catalyst for a Cure research consortium. Join us as we celebrate the scientists, advisors, donors, and volunteers who joined together to advance the field of glaucoma and bring us closer to our mission to cure glaucoma and restore vision.
It would mean so much to have you join us for this very special evening.
The Catalyst Award
Ronald L. Fellman, MD
Glaucoma Associates of Texas and The Cure Glaucoma Foundation
Ronald L. Fellman, MD joined the Glaucoma Associates of Texas in 1983 after completing his glaucoma fellowship at the Wills Eye Hospital in Philadelphia. His commitment to caring for patients with glaucoma is evident by his research endeavors and patient advocacy for more than 30 years. In 2014, he joined his colleagues by establishing The Cure Glaucoma Foundation to make a global impact in glaucoma research and care. In addition to global medical trips and surgical training efforts, The Cure Glaucoma Foundation has made critical investments to support the Steven and Michele Kirsch Catalyst for a Cure Vision Restoration Initiative. Glaucoma Research Foundation is honored to recognize Dr. Fellman for his outstanding contributions to the field of glaucoma and enduring dedication to improving the lives of people with glaucoma.
The Visionary Award
Steven and Michele Kirsch
Philanthropists and Co-founders, Catalyst for a Cure consortium
In 2001, Steven and Michele Kirsch inspired Glaucoma Research Foundation to establish the Catalyst for a Cure, an innovative collaborative research model to accelerate the pace of discovery. With their leadership support over the past 20 years, Steven and Michele have generously provided funding for three consortiums, each making critical discoveries toward our goal for a cure.
In 2021, Steven and Michele made a lead gift of $1.5 million to establish a matching challenge to provide funding for the current team of scientists focused on vision restoration. In recognition of this extraordinary gift, the consortium was named the Steven and Michele Kirsch Catalyst for a Cure Vision Restoration Initiative. Glaucoma Research Foundation is indebted to Steven and Michele for their unwavering partnership and remarkable investment toward a future free from glaucoma.
The President's Award
David J. Calkins, PhD
Assistant Vice President, Research, Vanderbilt University Medical Center
Chair, Glaucoma Research Foundation Research Committee, and
Chair, Steven and Michele Kirsch Catalyst for a Cure Scientific Advisory Board
David Calkins, PhD is a leading authority on the neurobiological basis of vision loss in blinding eye disease, neuroprotection and regenerative medicine for conditions that affect the retina and early visual pathways. As well as receiving over 60 research grants from the National Institutes of Health and many industry and foundation partners, Dr. Calkins has written more than 80 research articles, reviews and book chapters. He was a founding member of Glaucoma Research Foundation’s first Catalyst for a Cure team and now Chairs the Steven and Michele Kirsch Catalyst for a Cure Vision Restoration Initiative and our Research Committee. Glaucoma Research Foundation is incredibly grateful to Dr. Calkins for his ongoing leadership and exemplary commitment to advancing our scientific programs as well as his tremendous accomplishments in the field of glaucoma research.
To join the Host Committee, please contact Nancy Graydon at email@example.com
Registration will open soon.
The Annual Gala is part of Glaucoma 360, a series of events uniting research, industry, and philanthropy with one mission — to find a cure for glaucoma. Learn more about Glaucoma 360 »
For more information, please contact our Development Department at (415) 986-3162 or email firstname.lastname@example.org.